Zdrowie i gospodarka · 19/08/2020

FDA Releases Final Guidance on Bioavailability and Bioequivalence Sample Retention

The Food and Drug Administration (FDA) has released a final guidance outlining its policy on the quantity of reserve samples retained for bioavailability and bioequivalence testing, in response to technological advancements and industry requests.